News From the 2016 American Society of Hematology (ASH) Meeting

 

Patient Power was on-site at the 2016 American Society of Hematology (ASH) meeting in San Diego to bring you the latest blood cancer-related treatment and research news.

Published:

Published:

Published:

Published:

Published:

Published:

Published:

Published:

Published:

Published:

Evolving CML Research: Assessing the Need for Ongoing Treatment in Clinical Trials

Is there such thing as treatment-free remission for a CML patient? Dr. Jessica Altman of Robert H. Lurie Comprehensive Cancer Center of Northwestern University shares news from ASH 2016.

Published:

MPN News From ASH 2016: An Update From Dr. Claire Harrison

Hear what the latest MPN news from ASH 2016 means for patients with Dr. Claire Harrison of Guy and St. Thomas’ Hospital.

Published:

Published:

Published:

Published:

Updates in CML From ASH 2016: Reducing Therapy Safely

Learn how CML patients are safely reducing TKI therapy through a clinical trial in the UK. Researcher from the University of Glasgow, Dr. Mhairi Copland, reports.

Published:

Published:

Published:

MPN News From ASH 2016: Reviving the Role of Interferon Treatment

As part of our 2016 ASH coverage, Dr. John Mascarenhas joined Patient Power to discuss the research taking place with interferon as a treatment for MPNs.

Published:

Published:

Published:

Published:

Published:

Published:

Advertisement
tritt unserer Gemeinschaft bei Registrieren Sie sich für Veranstaltungen Lesen Sie unseren neuesten Blog
Advertisement

Page last updated on February 15, 2017